CoffmanJD. Raynaud's phenomenon. An update. Hypertension1991; 17: 593–602.
2.
BlainAIIICollerFACarverGB. Raynaud's disease. A study of criteria for prognosis. Surgery1951; 29: 387–97.
3.
VelayosEERobinsonHPorciunculaFUMasiAT. Clinical correlation analysis of 137 patients with Raynaud's phenomenon. Am J Med Sci1971; 262: 347–56.
4.
PorterJMBardanaEJJrBaurGMWescheDHAndraschRHRöschJ.The clinical significance of Raynaud's syndrome. Surgery1976; 80: 756–64.
5.
VayssairatMFiessingerJNHoussetE.Phénomène de Raynaud. Étude prospective de 100 cas. Nouv Med Presse1979; 8: 2177–80.
6.
CarpentierPFrancoA.Capillaroscopie et phénomène de Raynaud. J Mal Vasc1984; 9: 23–28.
7.
MoninAReggiM.Enquête étiologique d'un phénomène de Raynaud. Artères et Veines1985; 4: 303–309.
8.
JoyalFChoquetteDRoussinA. Nailfold capillary microscopy in Raynaud's phenomenon: A study of 454 patients. In: BoccalonH ed. Angiologie. Paris: John Libbey Eurotext, 1988: 535–36.
9.
MaricqHRMcGregorARDiatFSmithEAMaxwellDBLeRoyEC. Major clinical diagnoses found among subjects with Raynaud phenomenon from the general population. J Rheumatol1990; 17: 1171–76.
10.
EdwardsJMPorterJM. Associated diseases in patients with Raynaud's syndrome. Vascular Medicine Review1990; 1: 51–58.
11.
JablonskaS.Cutaneous lesions in systemic scleroderma (progressive systemic sclerosis). In: JablonskaS ed. Scleroderma and pseudoscleroderma. Warsaw: Polish Medical Publishers, 1975: 243–76.
12.
MedsgerTAJr. Systemic sclerosis (scleroderma), localized scleroderma, eosinophilic fasciitis, and calcinosis. In: McCartyDJ ed. Arthritis and allied conditions. A textbook of rheumatology. Philadelphia: Lea & Febiger, 1989: 1118–65.
EstesDChristianCL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine1971; 50: 85–95.
15.
DimantJGinzlerESchlesingerM. The clinical significance of Raynaud's phenomenon in systemic lupus erythematosus. Arthritis Rheum1979; 22: 815–19.
16.
CarrollGJWithersKBaylissCE. The prevalence of Raynaud's syndrome in rheumatoid arthritis. Ann Rheum Dis1981; 40: 567–70.
17.
AllenEBrownG.Raynaud's disease: A critical review of minimal requisites for diagnosis. Am J Med Sci1932; 83: 187–200.
18.
GiordanoMValentiniGMigliaresiSPicilloUVattiM.Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol1986; 13: 911–16.
19.
SarkoziJBookmanAAMLeePKeystoneECFritzlerMJ. Significance of anticentromere antibody in idiopathic Raynaud's syndrome. Am J Med1987; 83: 893–98.
20.
KallenbergCGMWoudaAAHoetMHVan VenrooijWJ. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: A six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis1988; 47: 634–41.
21.
SteenVDPowellDLMedsgerTAJr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum1988; 31: 196–203.
22.
JohanetCAgostiniMMVayssairatMAbuafN.Autoanticorps anti-Scl-70 et anticentromere. Marqueurs biologiques de 2 variétés diffèrentes de sclérodermic systémique. Presse Med1989; 18: 207–11.
23.
Jarzabek-ChorzelskaMBlaszczykMKolacinska-StraszZChorzelskiTJablonskaSMaulGG. Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma; comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion. Arch Dermatol Res1990; 282: 76–83.
24.
WeinerESHildebrandtSSenecalJ-L. Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. Arthritis Rheum1991; 34: 68–77.
25.
LombardWP. The blood pressure in the arterioles, capillaries, and small veins of the human skin. Am J Physiol1912; 29: 335–62.
26.
MüllerO.Die Kapillaren der menschlichen Körperoberfläche in gesunden und kranken Tagen. Stuttgart: Enke, 1922.
27.
MaricqHR. Nailfold capillary photography. In: MessmerKHammersenF eds. Progress in applied microcirculation. Techniques in clinical capillary microscopy. Basel: Karger, 1986: 11–27.
28.
BosleyPGHJ. A consideration of pathological morphology in the nailbed capillary network of human subjects. Bibl Anat1960; 1: 229–38.
29.
RouenLRTerryENDoftBHClaussRHRedischW.Classification and measurement of surface microvessels in man. Microvasc Res1972; 4: 285–92.
30.
HoutmanPMKallenbergCGMFidlerVWoudaAA. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease. J Rheumatol1986; 13: 556–63.
31.
StathamBNRowellNR. Quantification of the nailfold capillary abnormalities in systemic sclerosis and Raynaud's syndrome. Acta Derm Venereal (Stockholm)1986; 66: 139–43.
32.
LeffordFEdwardsJCW. Nailfold capillary microscopy in connective tissue disease: A quantitative morphological analysis. Ann Rheum Dis1986; 45: 741–49.
33.
MaricqHR. Comparison of quantitative and semiquantitative estimates of nailfold capillary abnormalities in scleroderma spectrum disorders. Microvasc Res1986; 32: 271–76.
34.
MahlerFKneubühlF.Application of fluorescein-tagged albumin in human nailfold capillaries. Bibl Anat1981; 20: 684–87.
35.
BollingerAButtiPBarrasJ-PTrachslerHSiegenthalerW.Red blood cell velocity in nailfold capillaries of man measured by a television microscopy technique. Microvasc Res1974; 7: 61–72.
36.
FagrellBFronekAIntagliettaM.A microscope-television system for studying flow velocity in human skin capillaries. Am J Physiol1977; 233: H318–21.
37.
ÖstergrenJFagrellB.Skin capillary blood cell velocity in man. Characteristics and reproducibility of the reactive hyperemia response. Int J Microcirc Clin Exp1986; 5: 37–51.
38.
MahlerFMuheimMHIntagliettaMBollingerAAnlikerM.Blood pressure fluctuations in human nailfold capillaries. Am J Physiol1979; 236: H888–93.
39.
TookeJEWilliamsSA. Capillary blood pressure. Adv Exp Med Biol1987; 220: 209–14.
40.
BollingerAJägerKRotenATimeusCMahlerF.Diffusion, pericapillary distribution and clearance of Na-fluorescein in the human nailfold. Pflugers Arch1979; 382: 137–43.
SchmidtCSchmittJVelckerJ.La capillaroscopie digitale dans la maladie de raynaud idiopathique. J Mal Vasc1983; 8: 43–45.
43.
BrownGEO'LearyPA. Skin capillaries in scleroderma. Arch Intern Med1926; 36: 73–88.
44.
Spencer-GreenGCroweWBoveKLevinsonJ.Correlation of muscle angiopathy with nailfold capillary abnormalities in childhood dermatomyositis. Bibl Anat1981; 20: 702–707.
45.
GertnerESukenikSGladmanDD. HLA antigens and nailfold capillary microscopy studies in patients with insulin dependent and noninsulin dependent diabetes mellitus and limited joint mobility. J Rheumatol1990; 17: 1375–79.
46.
MaricqHR. Widefield capillary microscopy. Technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum1981; 24: 1159–65.
47.
LeePLeungFY-KAlderdiceCArmstrongSK. Nailfold capillary microscopy in the connective tissue diseases: A semiquantitative assessment. J Rheumatol1983; 10: 930–38.
48.
MaricqHR. The microcirculation in scleroderma and allied diseases. In: DavisE ed. Advances in microcirculation. Basel: Karger, 1982; 17–52.
49.
ThompsonRPHarperFEMaizeJCAinsworthSKLeRoyECMaricqHR. Nailfold biopsy in scleroderma and related disorders. Correlation of histologic, capillaroscopie and clinical data. Arthritis Rheum1984; 27: 97–103.
50.
GranierFVayssairatMPriolletPHoussetE.Nailfold capillary microscopy in mixed connective tissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus. Arthritis Rheum1986; 29: 189–95.
51.
HarperFEMaricqHRTurnerRELidmanRWLeRoyEC. A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report. Am J Med1982; 72: 883–88.
52.
MaricqHRHarperFEKhanMMTanEMLeRoyEC. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol1983; 1: 195–205.
53.
MaricqHRWeinbergerABLeRoyEC. Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: A prospective study of patients with Raynaud's phenomenon. J Rheumatol1982; 9: 289–91.
54.
GerbrachtDDSteenVDZieglerGLMedsgerTAJrRodnanGP. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum1985; 28: 87–92.
55.
PriolletPVayssairatMHoussetE.How to classify Raynaud's phenomenon. Long-term follow-up study of 73 cases. Am J Med1987; 83: 494–98.
56.
FitzgeraldOHessEVO'ConnorGTSpencer-GreenG.Prospective study of the evolution of Raynaud's phenomenon. Am J Med1988; 84: 718–26.
57.
CarpentierPHMaricqHR. Microvasculature in systemic sclerosis. Rheum Dis Clin North Am1990; 16: 75–91.
58.
McGillNWGowPJ. Nailfold capillaroscopy: A blinded study of its discriminatory value in scleroderma, systemic lupus erythematosus, and rheumatoid arthritis. Aust N ZJ Med1986; 16: 457–60.
59.
CasparyLSchmeesCSchoetensackI. Alterations of the nailfold capillary morphology associated with Raynaud phenomenon in patients with systemic lupus erythematosus. J Rheumatol1991; 18: 559–66.
60.
StuderAHunzikerTLüitolfOSchmidliJChenDMahlerF.Quantitative nailfold capillary microscopy in cutaneous and systemic lupus erythematosus and localized and systemic scleroderma. J Am Acad Dermatol1991; 24: 941–45.
61.
MaricqHRLeRoyECD'AngeloWA. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum1980; 23: 183–89.
62.
MaricqHRLeRoyEC. Patterns of finger capillary abnormalities in connective tissue disease by ‘wide-field’ microscopy. Arthritis Rheum1973; 16: 619–28.
MaricqHRBlumeRSLeRoyEC. Wide-field study of nailfold capillary bed in disorders of connective tissue. In: DitzelJ ed. Sixth European Conference on Microcirculation, Aalborg, 1970. Basel: Karger, 1971: 116–22.
65.
MaricqHR. Prevalence of a high nailfold plexus visualization score (PVS) in the general population. Hum Biol1977; 49: 485–87.
66.
RanftJLammersenTHeidrichH.In vivo capillary-microscopical findings in patients with thrombangiitis obliterans, progressive systemic scleroderma, and rheumatoid arthritis, respectively. Klin Wochenschr1986; 64: 946–50.
67.
MaricqHR. Vinyl chloride disease. In: BlackCMMyersAR eds. Current topics in rheumatology. Systemic sclerosis (scleroderma). New York: Gower Medical Publishing Ltd, 1985; 105–13.
68.
MaricqHRJohnsonMNWhetstoneCLLeRoyEC. Capillary abnormalities in polyvinyl chloride production workers. Examination by in vivo microscopy. JAMA1976; 236: 1368–71.
69.
MaricqHRDarkeCSArchibaldRMcLLeRoyEC. In vivo observations of skin capillaries in workers exposed to vinyl chloride. An English-American comparison. Br J Ind Med1978; 35: 1–7.
70.
TaylorW.The vibration syndrome. New York: Academic Press, 1974.
71.
VayssairatMPatriBGuilmotJLHoussetEDubrisayJ.La capillaroscopie dans la maladie des vibrations. Presse Med1982; 11: 3111–15.
72.
VayssairatMPatriBMathieuJ-FLienardMDubrisayJHoussetE.Raynaud's phenomenon in chain saw users. Hot and cold finger systolic pressures and nailfold capillary findings. Eur Heart J1987; 8: 417–22.
73.
BellmuntJNavarroMMoralesS. Capillary microscopy is a potentially useful method for detecting bleomycin vascular toxicity. Cancer1990; 65: 303–309.
74.
MaricqHRDowneyJALeRoyEC. Standstill of nailfold capillary blood flow during cooling in scleroderma and Raynaud's syndrome. Blood Vessels1976; 13: 338–49.
75.
BollingerAFreyJJägerKFurrerJSegliasJSiegenthalerW.Patterns of diffusion through skin capillaries in patients with long-term diabetes. N Engl J Med1982; 307: 1305–10.
76.
BollingerAJägerKSiegenthalerW.Microangiopathy of progressive systemic sclerosis. Evaluation by dynamic fluorescence videomicroscopy. Arch Intern Med1986; 146: 1541–45.
77.
DiatFIntagliettaMWeinrichMCMaricqHR. Effect of temperature on capillary blood flow in scleroderma spectrum disorders and in Raynaud phenomenon. Int J Microcirc Clin Exp1986; 5: 259.
78.
MahlerFSanerHBossCAnnaheimM.Local cold exposure test for capillaroscopie examination of patients with Raynaud's syndrome. Microvasc Res1987; 33: 422–27.
79.
JacobsMJHMBreslauPJSlaafDWRenemanRSLemmensJAJ. Nomenclature of Raynaud's phenomenon: A capillary microscopic and hemorheologic study. Surgery1987; 101: 136–45.
80.
GrassiWFelderMThüring-VollenweiderUBollingerA.Microvascular dynamics at the nailfold in rheumatoid arthritis. Clin Exp Rheumatol1989; 7: 47–53.
81.
BollingerASaesseliBHoffmannUFranzeckUK. Intravital detection of skin capillary aneurysms by videomicroscopy with indocyanine green in patients with progressive systemic sclerosis and related disorders. Circulation1991; 83: 546–51.
82.
BrülisauerMBollingerA.Measurement of different human microvascular dimensions by combination of videomicroscopy with Na-fluorescein (NaF) and indocyanine green (ICG) in normals and patients with systemic sclerosis. Int J Microcirc Clin Exp1991; 10: 21–31.
83.
MartinMFRTookeJE. Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis. Br Med J1982; 285: 1688–90.
84.
HanesFM. Multiple hereditary telangiectases causing hemorrhage (hereditary hemorrhagic telangiectasia). Bulletin of the Johns Hopkins Hospital1909; 20: 63–73.
85.
MaireRSchnewlinGBollingerA.Videomikroskopische Untersuchungen von Teleangiektasien bei Morbus Osier und Sklerodermie. Schweiz Med Wochenschr1986; 116: 335–38.
86.
WallsEWBuchananTJ. Observations on the capillary blood vessels of the human nailfold. J Anat1956; 90: 329–36.
87.
NussbaumAISilverRMMaricqHR. Serial changes in nailfold capillary morphology in childhood dermatomyositis. [Brief Report]Arthritis Rheum1983; 26: 1169–72.
88.
SilverRMMaricqHR. Childhood dermatomyositis: Serial microvascular studies. Pediatrics1989; 83: 278–83.
89.
ChenZSilverRMAinsworthSKDobsonRLRustPMaricqHR. Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med1984; 77: 812–22.
90.
MaricqHRDiatFSmithEAFinkGEWeinrichMC. Frequency of antinuclear antibodies among subjects with ‘cold sensitivity’, primary Raynaud phenomenon and ‘pre-diagnostic’ systemic sclerosis. Arthritis Rheum1991; 34 (suppl): R30.